Michael A. Harris, PhD, Named American Diabetes Association’s 2017 Richard R. Rubin Award Recipient
May 31, 2017
Michael A. Harris, PhD, has been selected to receive the American Diabetes Association® (Association) 2017 Richard R. Rubin Award. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations. Dr. Harris will be recognized with this honor during the Association’s 77th Scientific Sessions, June 9-13, 2017, at the San Diego Convention Center. He will deliver the Richard R. Rubin Award Lecture titled, “Your Exclusion, My Inclusion: Treating the Most Challenging in Diabetes,” on Saturday, June 10.
Dr. Harris, currently Professor of Pediatrics at Oregon Health and Science University, is recognized for significant contributions that have improved the lives of youth with type 1 diabetes. Previously, Dr. Harris held a faculty appointment in the Department of Pediatrics at Washington University School of Medicine in St. Louis, Missouri for 13 years.
Dr. Harris was the primary developer of the Diabetes Self-Management Profile (DSMP), now considered the gold standard for assessing regimen adherence in youth with type 1 diabetes. He was instrumental in development and dissemination of the Behavioral Family Systems Therapy-Diabetes (BFST-D), an empirically validated behavioral intervention for improving adherence and glycemic control. He also conducted the first research to demonstrate the effectiveness of teleconferencing technology to deliver behavioral interventions to individuals with diabetes and their families.
“Dr. Harris’s career has provided us with concrete tools that have set the standard in behavioral aspects of diabetes,” said President of Health Care and Education of the Association Brenda Montgomery, RN, MSHS, CDE¹. “Congratulations to Dr. Harris on this achievement, and thank you for improving the lives of people with diabetes.”
Dr. Harris also developed and validated the nationally recognized Novel Interventions in Children’s Healthcare (NICH) to improve care and reduce the unnecessary hospitalization of children and adolescents with chronic health conditions, such as diabetes. Beyond his research efforts, his teaching, mentoring and collaborations exemplify his dedicated service to the field.
The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE, President of Health Care and Education, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts. Join the Scientific Sessions conversation on Twitter, #2017ADA.
About the American Diabetes Association
More than 30 million Americans have diabetes, and every 21 seconds another person is diagnosed with diabetes. The American Diabetes Association (Association) is the global authority on diabetes and since 1940 has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. To tackle this global public health crisis, the Association drives discovery in research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and provides support and advocacy for people living with diabetes, those at risk of developing diabetes and the health care professionals who serve them. For more information, please call the American Diabetes Association at 1-800-DIABETESS (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)
1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.